Dark Streaming/Mobile Old Site Home Products Help Contact Us Your Account System Status
Sign-up for a FREE 30-day Stockwatch subscription and SEE NO ADS
01:56:30 EDT Fri 19 Apr 2024
Enter Symbol
or Name
USA
CA



News for C:VPH from 2023-04-20 to 2024-04-19 - 35 items News ReleasesIn The NewsOther CAUS
DateSymCompanyPriceTypeHeadline
2024-03-22 09:27C:VPHValeo Pharma Inc0.175News ReleaseValeo Pharma appoints Moghaddam as director
2024-03-15 09:16C:VPHValeo Pharma Inc0.195SEDAR Interim Financial StatementsSEDAR Interim Financial Statements
2024-03-15 09:10C:VPHValeo Pharma Inc0.195SEDAR Interim Financial StatementsSEDAR Interim Financial Statements
2024-03-14 17:38C:VPHValeo Pharma Inc0.195News ReleaseValeo Pharma loses $6.9-million in Q1 2024
2024-03-14 16:18C:VPHValeo Pharma Inc0.195SEDAR Interim Financial StatementsSEDAR Interim Financial Statements
2024-03-14 16:12C:VPHValeo Pharma Inc0.195SEDAR Interim MD & ASEDAR Interim MD & A
2024-03-14 16:12C:VPHValeo Pharma Inc0.195SEDAR Interim Financial StatementsSEDAR Interim Financial Statements
2024-03-07 09:25C:VPHValeo Pharma Inc0.195News ReleaseValeo Pharma to release Q1 2024 results March 14
2024-02-13 11:04C:VPHValeo Pharma Inc0.175News ReleaseValeo Pharma appoints Raich, Bisaillon as directors
2024-02-02 17:13C:VPHValeo Pharma Inc0.26News ReleaseValeo Pharma amends supply agreement with Novartis
2024-01-29 18:39C:VPHValeo Pharma Inc0.33SEDAR Annual Information FormSEDAR Annual Information Form
2024-01-29 18:39C:VPHValeo Pharma Inc0.33SEDAR Annual ReportSEDAR Annual Report
2024-01-29 18:39C:VPHValeo Pharma Inc0.33SEDAR Audited Annual Financial StatementsSEDAR Audited Annual Financial Statements
2024-01-29 18:39C:VPHValeo Pharma Inc0.33SEDAR MD & ASEDAR MD & A
2024-01-29 18:05C:VPHValeo Pharma Inc0.33News ReleaseValeo Pharma loses $27.8-million in fiscal 2023
2024-01-22 10:16C:VPHValeo Pharma Inc0.33News ReleaseValeo Pharma to release fiscal 2023 results Jan. 29
2023-11-20 10:24C:VPHValeo Pharma Inc0.18News ReleaseValeo Pharma to reduce $2M in operating costs
2023-11-07 13:14C:VPHValeo Pharma Inc0.145News ReleaseValeo Pharma appoints Lajoie as director
2023-09-27 10:11C:VPHValeo Pharma Inc0.235News ReleaseValeo enters $5M credit facility agreement with Accord
2023-09-13 19:57C:VPHValeo Pharma Inc0.285News ReleaseValeo Pharma loses $5.8-million in Q3 2023
2023-09-13 16:53C:VPHValeo Pharma Inc0.285SEDAR Interim Financial StatementsSEDAR Interim Financial Statements
2023-09-13 16:53C:VPHValeo Pharma Inc0.285SEDAR Interim Financial StatementsSEDAR Interim Financial Statements
2023-09-13 16:53C:VPHValeo Pharma Inc0.285SEDAR Interim MD & ASEDAR Interim MD & A
2023-09-07 13:20C:VPHValeo Pharma IncNews ReleaseValeo Pharma to release Q3 2023 results Sept. 13
2023-09-01 14:11C:VPHValeo Pharma Inc0.315SEDAR Early Warning ReportSEDAR Early Warning Report
2023-08-31 18:25C:VPHValeo Pharma Inc0.315News ReleaseValeo closes $3.92M financing, secures $580,000 loan
2023-07-04 10:01C:VPHValeo Pharma Inc0.385News ReleaseValeo notes sale of Novartis products to Bausch + Lomb
2023-06-22 07:25C:VPHValeo Pharma Inc0.37News ReleaseValeo Pharma appoints Close, Leconte to board
2023-06-13 18:50C:VPHValeo Pharma Inc0.355News ReleaseValeo Pharma loses $6.5-million in Q2 2023
2023-06-13 16:44C:VPHValeo Pharma Inc0.355SEDAR MD & ASEDAR MD & A
2023-06-13 16:43C:VPHValeo Pharma Inc0.355SEDAR Interim Financial StatementsSEDAR Interim Financial Statements
2023-06-13 16:43C:VPHValeo Pharma Inc0.355SEDAR Interim Financial StatementsSEDAR Interim Financial Statements
2023-06-07 12:13C:VPHValeo Pharma Inc0.345News ReleaseValeo Pharma to release Q2 2023 results June 13
2023-05-25 12:30C:VPHValeo Pharma Inc0.425News ReleaseValeo Pharma expects Q2 revenues to exceed $13.5M
2023-04-28 10:13C:VPHValeo Pharma Inc0.495News ReleaseValeo holders elect six directors at annual meeting